Key facts
- It has raised $500K.
- Notable investors include Innovate UK, UK Research and Innovation, Zinc, GC Angels, Pioneer Group — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Prorizon
- ·The full record, as it builds
Funding rounds
No funding rounds for Prorizon are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Prorizon
Developer of a digital health platform intended to monitor and track other health records. The company's platform offers features like digital precision health technology, integrating biopsychosocial metrics, phenotyping, and machine learning, enabling athletes and coaches to manage their health and performance.
- Sector
- Healthcare
- HQ
- Mildenhall, United Kingdom
- Founded
- 2022
- Employees
- 5
- Website
- prorizon.tech/
- Ownership
- Privately Held (backing)
Prorizon doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Prorizon shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Prorizon in its N-PORT filings yet. We sweep new filings monthly.